CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 892,857 shares (grant or award)
- 4 Grant or award Director acquired 446,428 shares (grant or award)
- 4 Grant or award Director acquired 406,250 shares (grant or award)
- 4 Grant or award Director acquired 4,464 shares (grant or award)
- 4 Grant or award Director acquired 44,642 shares (grant or award)
- 4 Grant or award Director acquired 133,928 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4/A Grant or award Director acquired 11,640 shares (grant or award)
- 4 Grant or award Director acquired 11,439 shares (grant or award)
- 4 Grant or award CFO acquired 200 shares (grant or award)
Page 7 of 38 · 746 filings